Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCS) Equity Ratio (2022 - 2026)

HeartSciences (HSCS) has disclosed Equity Ratio for 4 consecutive years, with 0.7 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 35.06% year-over-year to 0.7, compared with a TTM value of 0.7 through Oct 2025, up 35.06%, and an annual FY2025 reading of 0.05, down 93.69% over the prior year.
  • Equity Ratio was 0.7 for Q4 2025 at HeartSciences, up from 0.49 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.8 in Q1 2024 and bottomed at 2.9 in Q2 2022.
  • Average Equity Ratio over 4 years is 0.09, with a median of 0.31 recorded in 2025.
  • The sharpest move saw Equity Ratio plummeted 406.93% in 2023, then surged 1178.7% in 2024.
  • Year by year, Equity Ratio stood at 0.23 in 2022, then tumbled by 406.93% to 0.7 in 2023, then soared by 174.15% to 0.52 in 2024, then soared by 35.06% to 0.7 in 2025.
  • Business Quant data shows Equity Ratio for HSCS at 0.7 in Q4 2025, 0.49 in Q3 2025, and 0.05 in Q2 2025.